Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1Classical hematology 1

Conditions

Patient Participation 1Multiple Myeloma 1Lymphoma 1Febrile Neutropenia 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × TKN732 × Clear all
NCT06116734 2023-11-03

Lapelga vs Gastrofil

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 3 Unknown
74 enrolled
Classical hematologyLymphoidPlasma cell

Lymphoma, Multiple Myeloma, Patient Participation, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡